Clinical Trials Browser

Phase 2 × Adenocarcinoma, Clear Cell × Sunitinib × Clear all

NCT01824615 2018-07-18

Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma

Phase 2 Completed

Ovarian Neoplasms, Adenocarcinoma, Clear Cell